Neurogen Corporation, 35NE Industrial Road, Branford, CT 06405, USA.
Abstract:
The discovery, synthesis and structure-activity studies of a novel series of 2-arylpyrimidin-4-ones as CRF-1 receptor antagonists is described. These compounds are structurally simple and display appropriate physical properties for CNS agents